AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NOVA EYE MEDICAL LTD

0.165

-0.005-2.94%

Volume:577.80K

Turnover:93.57K

Market Cap:47.00M

PE:-4.50

High:0.170

Open:0.170

Low:0.160

Close:0.170

52wk High:0.205

52wk Low:0.086

Shares:284.83M

Float Shares:240.54M

Volume Ratio:0.63

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.037

EPS(LYR):-0.037

ROE:-44.96%

ROA:-19.92%

PB:2.48

PE(LYR):-4.50

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BRIEF-Nova Eye Medical Posts December Quarter Sales Of $6.1 Million

Nova Eye Medical - December Quarter Sales of US$6.1 Mln

THOMSON REUTERS

Nova Eye Medical Says Statistical Report Backs Efficacy, Safety of Eye Surgery Device; Shares Up 3%

MT Newswires Live

There's No Escaping Nova Eye Medical Limited's (ASX:EYE) Muted Revenues Despite A 28% Share Price Rise

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EYE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"EYE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","market":"AU","secType":"STK","nameCN":"NOVA EYE MEDICAL LTD","latestPrice":0.165,"timestamp":1770354720000,"preClose":0.17,"halted":0,"volume":577795,"delay":0,"changeRate":-0.029411764705882377,"nameEN":"NOVA EYE MEDICAL LTD","floatShares":240542047,"shares":284833284,"eps":-0.036626,"marketStatus":"Market Closed","change":-0.005,"latestTime":"02-06 16:12:00 AEDT","open":0.17,"high":0.17,"low":0.16,"amount":93565,"amplitude":0.058824,"askPrice":0.165,"askSize":116708,"bidPrice":0.16,"bidSize":50000,"shortable":3,"etf":0,"ttmEps":-0.036626,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.17,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":0.6271073344790817,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","floatShares":240542047,"roa":"-19.92%","roe":"-44.96%","lyrEps":-0.036626,"volumeRatio":0.6271073344790817,"shares":284833284,"dividePrice":0,"high":0.17,"amplitude":0.058824,"preClose":0.17,"low":0.16,"week52Low":0.086,"pbRate":"2.48","psRate":"1.61","week52High":0.205,"institutionHeld":0,"latestPrice":0.165,"committee":-0.400149,"eps":-0.036626,"divideRate":0,"volume":577795,"delay":0,"ttmEps":-0.036626,"open":0.17,"prevYearClose":0.132,"prevWeekClose":0.185,"prevMonthClose":0.185,"prevQuarterClose":0.132,"fiveDayClose":0.185,"twentyDayClose":0.15,"sixtyDayClose":0.13,"dividendGrowthYears":0,"dividendGrowthRate":-1,"fiveYearAvgDividendRate":1.3621794871794872},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYE.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-01","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769900400000,"name":null,"time":"","dateTimestamp":1769864400000,"actualEps":null},{"date":"2025-10-27","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761519600000,"name":null,"time":"","dateTimestamp":1761483600000,"actualEps":null},{"market":"AU","date":"2024-02-13","symbol":"EYE.AU","defaultRemindTime":1707778800000,"type":"split","dateTimestamp":1707742800000,"forFactor":973737,"toFactor":1000000,"ratio":0.973737},{"date":"2023-08-28","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null},{"date":"2023-02-27","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677452400000,"name":null,"time":"","dateTimestamp":1677416400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYE.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-07-21","recordDate":"2020-07-22","paymentDate":"2020-07-29","value":0.135,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607720460","title":"BRIEF-Nova Eye Medical Posts December Quarter Sales Of $6.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607720460","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607720460?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:30","pubTimestamp":1769650252,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Posts December Quarter Sales Of $6.1 MillionJan 29 (Reuters) - Nova Eye Medical Ltd EYE.AX:DECEMBER QUARTER SALES OF US$6.1 MILLIONFurther company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT16G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYE.AU","BK7007"],"gpt_icon":0},{"id":"2607738723","title":"Nova Eye Medical - December Quarter Sales of US$6.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607738723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607738723?lang=en_us&edition=fundamental","pubTime":"2026-01-29 05:45","pubTimestamp":1769636700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT16G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EYE.AU"],"gpt_icon":0},{"id":"2606272168","title":"Nova Eye Medical Says Statistical Report Backs Efficacy, Safety of Eye Surgery Device; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606272168","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606272168?lang=en_us&edition=fundamental","pubTime":"2026-01-27 12:57","pubTimestamp":1769489877,"startTime":"0","endTime":"0","summary":"Nova Eye Medical  said the success rate in intraocular pressure reduction in patients with baseline intraocular pressure greater than 18 millimeters of mercury  was 85% in its 2025 statistical report on progress of patients in the iTrack Global Data Registry, an independently managed database, according to a Tuesday Australian bourse filing.Over 400 eyes reached the 12-month follow-up point under the registry, the filing said. Patients experienced a mean 40% reduction in medication burden across the group. There were six reported adverse events.The outcomes were considered clinically meaningful, per the filing, compared with other minimally invasive glaucoma surgery procedures.Nova Eye Medical's shares rose nearly 3% in recent trading on Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EYE.AU"],"gpt_icon":0},{"id":"2604616582","title":"There's No Escaping Nova Eye Medical Limited's (ASX:EYE) Muted Revenues Despite A 28% Share Price Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2604616582","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604616582?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:28","pubTimestamp":1768861702,"startTime":"0","endTime":"0","summary":"Nova Eye Medical Limited ( ASX:EYE ) shareholders would be excited to see that the share price has had a great month...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/theres-no-escaping-nova-eye-medical-limiteds-asxeye-muted-re","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/theres-no-escaping-nova-eye-medical-limiteds-asxeye-muted-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE.AU","EYE","ELXMF"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EYE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}